ARE Labs has personnel with experience in performing complete aerosol delivery system development and testing for the exposure of various non–human animal models for testing of vaccines against an array of biological threat aerosols. Experience includes specializing in LD50 determination, vaccine efficacy against LD50 equivalent aerosol challenge doses of toxins, and multiple pathogenic organism challenges including anthrax, plague, and influenza.

Although we do not yet have the infrastructure required to lead vaccine efficacy studies, we can help setup a custom exposure system, characterize and validate it, deliver the system, write SOP’s, train your staff and conduct the exposures at your facilities.  Our services will give allow you to conduct your vaccine efficacy study in-house and expand your capabilities.

ARE Lab’s staff have decades of experience with controlled exposures for vaccine efficacy studies and have worked with a large variety of BSL2 exposure testing, BSL3 exposure testing and chemical surety agent exposures for vaccine efficacy testing.